Holdings
126
Well diversified
Top 10 weight
55%
Concentration
Active share
-
Style
Equity
100%
Asset allocation
Portfolio
5Sectors
13High-conviction bets
98%Top sector wt.
0.1%Cash
Market-cap allocation
Large cap45%
Mid cap28%
Small cap27%
Asset allocation
Equity100%
Top holdings
13.9%
Divis Laboratories LtdEQUITY
5.9%5.7%
5.6%
Cipla LtdEQUITY
5.3%5.2%
Lupin LtdEQUITY
4.0%Fortis Healthcare LtdEQUITY
3.4%Laurus Labs LimitedEQUITY
3.0%3.0%
Aurobindo Pharma LtdEQUITY
2.8%2.6%
2.3%
Biocon LtdEQUITY
1.9%Mankind Pharma LimitedEQUITY
1.8%Zydus Lifesciences LtdEQUITY
1.6%IPCA Laboratories LtdEQUITY
1.5%1.3%
1.2%
1.0%
Gland Pharma LimitedEQUITY
1.0%1.0%
Abbott India LtdEQUITY
0.9%Neuland Laboratories LtdEQUITY
0.9%0.9%
Ajanta Pharma LtdEQUITY
0.9%Wockhardt LtdEQUITY
0.8%Dr. Lal Pathlabs LimitedEQUITY
0.8%Granules India LimitedEQUITY
0.7%Piramal Pharma LimitedEQUITY
0.7%Natco Pharma LtdEQUITY
0.7%0.7%
0.7%
Global Health LimitedEQUITY
0.7%0.6%
0.6%
0.6%
0.5%
Pfizer LtdEQUITY
0.5%0.5%
0.5%
Poly Medicure LimitedEQUITY
0.4%0.4%
0.4%
0.4%
Indegene LimitedEQUITY
0.4%0.4%
Shilpa Medicare LtdEQUITY
0.3%0.3%
AI Smart summary
Pros
- Well-diversified across 126 holdings.
Cons
- No major structural red flags.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
1.3%
0.3%
0.3%
0.1%